AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Cholesterol, metabolic health and heart disease | Dr Alan Flanagan and Danny Lennon
The Proof with Simon Hill
LP a Little Layer
LP looks like it's probably going to be declared the kind of the second causal biomarker for atherosclerotic cardiovascular disease. The previous interventions that have all been on the major LDL lowering drugs that we have really don't directly target LP a little A. It seems to be primarily driven by genetics. There's very little evidence that we have that diet that makes a kind of a meaningful difference to LP little A.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode